In addition, the use of other ligands, such as the selective ATR1 antagonist ZD7155 in the kainate-induced epilepsy model in hypertensive and normal rats, has been investigated to further understand the new targeted therapy for the prevention and better management of epilepsy. This evidence concerns the gene AGTR1 and epilepsy.